from cells to organelles

Boost your Drug Discovery
with organelles

Boost your Drug Discovery with organelles

Oria Bioscience is a pionnering French TechBio company, expert in generating organelles.

For the first time, access organelles compatible with pharmaceutical requirements in terms of volume (HTS compatible), quality and stability.

Shift your focus from cells to organelles to catch cutting-edge therapeutics opportunities.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Accelerate your Drug Discovery

We purify high quality organelles in microfluidics with a unique patented process developed at ENS Paris - CNRS.
Work at organelle scale to develop your next First-in-Class molecule

Pharma Laboratories

Improve your Hit-to-Lead and Lead Optimization selectivity with organelle based-screening

CRO

Conduct you high throughput screening on ready-to-use lysosomes

Biotech Company

De-risk your assets and grow your pipeline by testing your mechanism of action on organelles

Academic laboratories

Conduct your research with unlimited and high-quality organelles

THerapeutic potential of organelles

Organelle key functions

Dysfunctions in cellular organelles can trigger numerous neurodegenerative diseases, rare diseases, cardiovascular diseases, cancers...

Lysosomes

Lysosomes act as the recycling centers of cells, breaking down waste materials and cellular debris. Dysfunctions in the lysosome can generate diseases such as neurodegenerative disorders (Alzheimer’s, Parkinson’s…), as well as certain types of cancers.

TARGETS
TMEM175, TRPML1, ATP13A2...

Mitochondria

Mitochondria are the powerhouses of cells, generating the energy required for cellular functions. Dysfunctions in mitochondria can lead to various diseases, including metabolic disorders and certain types of muscular and neurological conditions.

TARGETS
MCU, IMAC, NRS2...

Endoplasmic Reticulum

The endoplasmic reticulum is crucial for protein and lipid synthesis, as well as the detoxification of chemicals within cells. Dysfunctions in the  reticulum can cause diseases such as diabetes, liver disease, and neurodegenerative disorders.

TARGETS
IP3R, SERCA, RYR...

Our Offers

3 ways to work with us

Our in-house lysosome preparation

Receive your HEK-lysosomes from our in house cell-lines. Our Lyso-Prep is compatible with you screening platform,  they can be native or with an overexpressed target.

Customize organelle preparation

Receive your lysosomal preparations from your own HEK-cell lines

Collaborate to develop your own organelle preparations

Work in collaboration on new cell-lines, new organelles or new targets

Contact Us
WHY CHOOSE US

Innovation, Acceleration, Impact

At Oria Bioscience, we forge strong, personalized partnerships to advance organelle research. Our team is committed to using its expertise to deliver high-quality solutions that will significantly enhance your success and innovation.

Create Account - Elements Webflow Library - BRIX Templates
Unmatched Support

Experience unparalleled support and expertise in organelle research

Download App - Elements Webflow Library - BRIX Templates
High-quality Solutions

Access high quality and reliable solutions designed for your specific R&D projects.

Start Our App - Elements Webflow Library - BRIX Templates
Expert Collaboration

Collaborate with industry-leading scientists and researchers to achieve groundbreaking results

Meet the founding team

With a diverse range of skills and extensive experience, we are committed to advancing scientific discoveries and delivering groundbreaking solutions

Alexandre SANTHINO, PhD

Chief Executive Officer
Graduated from Agro-ParisTech and ESPCI Paris, Alexandre holds a PhD in biophysics from ENS-PSL.
During this PhD, he met Abdou-Rachid, and developed the technology at the origin of Oria.
He leads Oria since 2021, driving the company's strategy and cementing a strong, innovative team.
Linkedin - Elements Webflow Library - BRIX Templates

Abdou-Rachid THIAM, PhD

Chief Scientist Officer
Research director at ENS, Abdou-Rachid is an organelle expert with more than 20 years of experience. He built his in-depth knowledge working with Medicine Nobel Price James Rothman on intracellular traffic.
Inventor of 5 patents and author of over 50 publications, he leads R&D and innovation at Oria Bioscience.
Linkedin - Elements Webflow Library - BRIX Templates

Marine MOUTIA

Chief Operations Officer
Graduated from Institut d'Optique and HEC Paris Marine is a specialist of Bioentreprenorship. Working in a Private Equity fund she also consolidated her
operational and financial skills.
She structures the company and leads the financial strategy.
Linkedin - Elements Webflow Library - BRIX Templates

They Support Us

Our Key Achievements

1.5
M€

Funded

200
x

Faster on lysosome screening

2
Targets

Validated

5
+

Industrial partners

Frequently Asked Questions

Find answers to common questions about our product, services, technologies, and how Oria Bioscience can support your research needs.

What product does Oria Bioscience offer?

Oria Bioscience offers batches of purified organelles from HEK-cells, overexpressing the targets you need.

Can Oria Bioscience purify organelles from my own cell lines ?

Oria Bioscience can purify organelles from your own cell lines. It will include a additionnal R&D service fee.

Does Oria's process preserve organelle functionnality ? 

Oria's smooth purification precess prevserve the integrity of the organelle and the activity of the various proteins (ion channels, transporters, enzymes...). The functionality can be preserve up to 21 days and can be sent worldwide. 

What can I do with your lysosomes?

Our lysosomes are compatible with APC technologies and SSM-Electrophysiology. Our batches of lysosome allow to test 5 to 10 384-plates per day. Other applications such as fluorescence screening are under development.